Try our Advanced Search for more refined results
Life Sciences
- 
									August 29, 2025
									Pharmaceutical Cos. Back Lilly In Mich. Insulin Pricing ProbeA trade association representing pharmaceutical companies told the Michigan Supreme Court the state attorney general's investigation into Eli Lilly's insulin prices is based on "incorrect and unworkable" legal theories. 
- 
									August 29, 2025
									Ill. Jury Sides With Ex-CTA Worker In Vax Bias LawsuitAn Illinois federal jury on Friday awarded a former Chicago Transit Authority employee $425,000 in damages, finding the transit agency liable on his religious discrimination claim after he was terminated following his refusal to take the COVID-19 vaccine and denied an exemption to the agency's vaccine requirement. 
- 
									August 29, 2025
									House Dems Reintroduce Marijuana Legalization Bill AgainDemocrats in the U.S. House of Representatives once again reintroduced a federal marijuana legalization bill that previously passed the chamber twice when it was under Democratic control, but has never gained traction in the U.S. Senate or under a majority-Republican House. 
- 
									August 29, 2025
									Ex-NephroSant CEO Gets Docs Claim Tossed In Fee RowA Delaware vice chancellor has granted a request from NephroSant Inc.'s founder and former CEO to toss a counterclaim alleging she unlawfully accessed and deleted confidential company documents amid an investigation into her conduct, as she continues to fight to have the company cover her legal costs. 
- 
									August 29, 2025
									NeoGenomics Scores Win In Natera DNA Test Patent SuitA North Carolina federal judge put an end to genetic testing company Natera Inc.'s lawsuit accusing NeoGenomics Laboratories Inc. of patent infringement over DNA cancer test technology, finding the patent claims at issue are invalid. 
- 
									August 29, 2025
									Taxation With Representation: White & Case, Paul WeissIn this week's Taxation With Representation, private equity firm Sycamore Partners completes its $24 billion acquisition of Walgreens Boots Alliance Inc., telecommunications company EchoStar sells wireless spectrum licenses to AT&T and Keurig Dr Pepper acquires JDE Peet's in a deal that aims to create a "global coffee champion." 
- 
									August 28, 2025
									3rd Circ. Agrees Natera Doesn't Owe $45M In False Ad FightThe Third Circuit Thursday affirmed a lower court's decision to take genetic testing company Natera off the hook from paying $45 million in damages to rival CareDx, saying in an unpublished opinion that CareDx failed to prove Natera actually deceived consumers through false statements about a Natera test's superiority. 
- 
									August 28, 2025
									CBP, ITC Say Masimo Suit Over Apple Watch Ruling MisplacedThe U.S. International Trade Commission and U.S. Customs and Border Protection balked at Masimo's request that a D.C. federal court temporarily block a ruling allowing imports of redesigned Apple Watches despite the companies' patent dispute, saying it's seeking relief in the wrong places. 
- 
									August 28, 2025
									Del. Judge Rejects J&J Unit's $12M Interference ClaimJohnson & Johnson unit DePuy Synthes Sales Inc. could not persuade a Delaware federal judge that it invented the technology behind an RSB Spine LLC spinal fusion surgery patent a jury says it owes $12 million for infringing. 
- 
									August 28, 2025
									2nd Circ. Affirms Hedge Fund Win In $87M Short-Swing SuitA unanimous Second Circuit panel on Thursday upheld a summary judgment win for hedge fund Armistice Capital LLC and its managing member in a derivative suit brought by a shareholder of biotechnology company Vaxart Inc., which sought disgorgement of $87 million in short-swing profits that allegedly were wrongfully obtained by the investment adviser. 
- 
									August 28, 2025
									Kimberly-Clark To Pay $40M Over Adulterated Surgical GownsKimberly-Clark agreed to pay up to $40 million to resolve federal prosecutors' criminal charge that the multinational consumer goods and personal care company sold adulterated surgical gowns and conducted fraudulent testing on the gowns to avoid having to submit a new premarket notification to the FDA. 
- 
									August 28, 2025
									Local Gov'ts Seek Win In Suit Over HHS-Canceled GrantsFour local governments and a union asked a D.C. federal judge on Wednesday to declare that the U.S. Department of Health and Human Services acted unlawfully when it canceled $11 billion in grants awarded to improve public health systems around the country. 
- 
									August 28, 2025
									DOJ Seeks Kroger Patient Data In Opioid FCA ProbeThe U.S. Department of Justice urged an Ohio federal court to order The Kroger Co. to turn over patient names and other health information the supermarket chain has redacted in responses to the government throughout a False Claims Act investigation into its opioid dispensing practices. 
- 
									August 28, 2025
									FTC Unpauses Administrative Case Over Insulin PricesThe Federal Trade Commission has restarted its in-house case accusing Caremark Rx, Express Scripts and OptumRx of artificially inflating insulin prices, now that two commissioners are able to consider the claims. 
- 
									August 28, 2025
									Mylan Must Face Generic Drug Price-Fixing Claims In MDLA Pennsylvania federal judge shot down most of Mylan's request for an early win in multidistrict litigation claiming price-fixing of the generic antidepressant clomipramine, finding sufficient evidence for the company to have to face direct buyers' claims at trial, but trimming claims that it inflated the drug's price at CVS. 
- 
									August 28, 2025
									Religion Didn't Drive Ex-CTA Worker's Vax Refusal, Jury HearsA former Chicago Transit Authority electrician hasn't met his burden of proving religious discrimination was behind his termination when he refused to be vaccinated against COVID-19, and his refusal was based on personal preference and health and safety concerns about the jab, an Illinois federal jury heard Thursday. 
- 
									August 28, 2025
									AstraZeneca Challenges Colo. Law Over Drug Pricing RulesPharmaceutical giant AstraZeneca told a Colorado federal judge Wednesday that a recently passed state law aiming to extend a federal drug discount program to certain pharmacies is preempted by the same law that created the program. 
- 
									August 28, 2025
									J&J Unit Can't Shake $442M Loss In Catheter Antitrust SuitA California federal judge has refused to upend the $442 million trial loss of Johnson & Johnson's Biosense Webster health tech unit to Innovative Health, finding the jury was presented with sufficient evidence to fault Biosense for conditioning product support for its cardiac mapping systems on the purchase of cardiac catheters. 
- 
									August 28, 2025
									1st Circ. OKs Terminating Ex-Pharma VP's Disability BenefitsThe First Circuit said Synta Pharmaceuticals' benefits administrator may terminate the benefits of a former executive after deeming that his significant weight loss, six-day-a-week pickleball hobby, and travels to far-flung places like Africa showed he was no longer disabled. 
- 
									August 28, 2025
									Bradley Arant Taps Parker Hudson Healthcare Atty In AtlantaBradley Arant Boult Cummings LLP announced Thursday that it continued its Atlanta growth with the addition of a new healthcare practice group partner from Parker Hudson Rainer & Dobbs LLP. 
- 
									August 28, 2025
									Sycamore Closes $24B Walgreens Deal, Replaces CEONew York-based private equity firm Sycamore Partners has completed its $24 billion acquisition of Walgreens Boots Alliance Inc., and the pharmacy chain named a new CEO, the companies announced Thursday. 
- 
									August 28, 2025
									Telehealth Co. Faces Investor Suit Over Revenue ReversalTelemedicine company LifeMD Inc. and two of its executives face a proposed investor class action alleging they "recklessly" raised revenue expectations for the 2025 fiscal year in May, only to lower their forecast three months later after seeing increased costs affecting the company's men's health and weight management offerings. 
- 
									August 28, 2025
									SC Ends Sandoz, Novartis Price-Fixing Claims For $2.4MA Connecticut federal judge on Thursday approved South Carolina's request to dismiss its generic drug price-fixing claims from three multistate lawsuits against Sandoz Inc., Sandoz AG, Novartis AG and Fougera Pharmaceuticals Inc., four months after the parties filed a notice of settlement. 
- 
									August 28, 2025
									Fed. Circ. Won't Upend Toss Of Flu Vaccine Injury ClaimThe Federal Circuit won't revive a man's vaccine injury claim after it was rejected by a special master at the U.S. Court of Federal Claims, finding the decision that his injuries were caused by a separate infection was not arbitrary or capricious. 
- 
									August 27, 2025
									HHS Says CDC Head Has Been Fired. She Says Otherwise.Centers for Disease Control and Prevention director Susan Monarez said Wednesday that she's not resigning and also that she cannot be terminated except by the president himself, issuing a statement after CDC parent agency U.S. Department of Health and Human Services said she was "no longer director." 
Expert Analysis
- 
								
								How Attys Can Use A Therapy Model To Help Triggered Clients  Attorneys can lean on key principles from a psychotherapeutic paradigm known as the "Internal Family Systems" model to help manage triggered clients and get settlement negotiations back on track, says Jennifer Gibbs at Zelle. 
- 
								
								3 Steps For In-House Counsel To Assess Litigation Claims  Before a potential economic downturn, in-house attorneys should investigate whether their company is sitting on hidden litigation claims that could unlock large recoveries to help the business withstand tough times, says Will Burgess at Hilgers Graben. 
- 
								
								J&J's Failed 3rd Try Casts Doubt On Use Of 'Texas Two-Step'  A Texas bankruptcy court recently rejected Johnson & Johnson's third attempt to use Chapter 11 to resolve liabilities from allegations of injuries from using talcum powder, suggesting that the U.S. Supreme Court's limitations on nondebtor releases, from 2024's Purdue Pharma ruling, may prove difficult to evade, say attorneys at Cadwalader. 
- 
								Series Teaching College Students Makes Me A Better Lawyer  Serving as an adjunct college professor has taught me the importance of building rapport, communicating effectively, and persuading individuals to critically analyze the difference between what they think and what they know — principles that have helped to improve my practice of law, says Sheria Clarke at Nelson Mullins. 
- 
								
								Why Attys Should Get Familiar With Quantum Computing  Quantum computing is projected to pose significant updates to current practices in cryptography, making the issue relevant to policymakers and the legal profession generally, particularly when it comes to data storage, privacy regulations and pharmaceutical industry market changes, say professors at the University of San Francisco. 
- 
								Series Adapting To Private Practice: From DOJ Enviro To Mid-Law  Practitioners leaving a longtime government role for private practice — as when I departed the U.S. Department of Justice’s environmental enforcement division — should prioritize finding a firm that shares their principles, values their experience and will invest in their transition, says John Cruden at Beveridge & Diamond. 
- 
								
								Legal Ethics Considerations For Law Firm Pro Bono Deals  If a law firm enters into a pro bono deal with the Trump administration in exchange for avoiding or removing an executive order, it has an ethical obligation to create a written settlement agreement with specific terms, which would mitigate some potential conflict of interest problems, says Andrew Altschul at Buchanan Angeli. 
- 
								
								Reproductive Health Under Trump So Far, And What's Next.jpg)  Based on priorities stated so far, the Trump administration will likely continue to weaken Biden-era policies that protect reproductive health, with abortion, in vitro fertilization and contraception all being issues to watch closely amid a post-Dobbs shift, say attorneys at McDermott. 
- 
								Series Playing Football Made Me A Better Lawyer  While my football career ended over 15 years ago, the lessons the sport taught me about grit, accountability and resilience have stayed with me and will continue to help me succeed as an attorney, says Bert McBride at Trenam. 
- 
								
								10 Arbitrations And A 5th Circ. Ruling Flag Arb. Clause Risks  The ongoing arbitral saga of Sullivan v. Feldman, which has engendered proceedings before 10 different arbitrators in Texas and Louisiana along with last month's Fifth Circuit opinion, showcases both the risks and limitations of arbitration clauses in retainer agreements for resolving attorney-client disputes, says Christopher Blazejewski at Sherin and Lodgen. 
- 
								
								Keys To Handling Digital Investigations In Pharma IP Litigation.jpg)  In the high-stakes realm of pharmaceutical intellectual property litigation, efficient e-discovery and digital investigation workflows are essential to supporting strategic arguments, building defensible cases and proving that the requirements for market entry have been adequately met, says Jerry Lay at FTI Consulting. 
- 
								Series Power To The Paralegals: The Value Of Unified State Licensing  Texas' proposal to become the latest state to license paraprofessional providers of limited legal services could help firms expand their reach and improve access to justice, but consumers, attorneys and allied legal professionals would benefit even more if similar programs across the country become more uniform, says Michael Houlberg at the University of Denver. 
- 
								
								What's Next For Lab Test Regulation Without FDA Authority  A recent Texas federal court decision vacating the U.S. Food and Drug Administration's final rule that would apply FDA regulations to laboratory-developed tests signals potential positive impacts in the diagnostic space, and could inspire more healthcare entities to litigate against the government, say attorneys at Hooper Lundy. 
- 
								
								10 Soft Skills Every GC Should Master  As businesses face shifting regulatory and technological uncertainty, general counsel will need to strengthen certain soft skills to succeed, from admitting when they make a mistake to maintaining a healthy dose of dispassion, says Douglas Brown at Manatt. 
- 
								
								6 Criteria Can Help Assess Executive Branch Actions.jpg)  With new executive policy changes announced seemingly every day, several questions can help courts, policymakers and businesses determine whether such actions are proper, effective and in keeping with our democratic norms, say Marc Levin and Khalil Cumberbatch at the Council on Criminal Justice.